A subjective syndrome that occurs following standard antibiotic treatment of Lyme disease. It includes FATIGUE; MUSCULOSKELETAL PAIN; and neurocognitive dysfunction.
| Synonym |
|---|
| Post Lyme Disease Syndrome |
| Post-Treatment Lyme Disease Syndrome |
| Post-Treatment Lyme Disease |
| Post-Lyme Disease Syndrome |
| Chronic Lyme Disease |
| Timeframe | Studies, This Condition (%) | All Conditions % |
|---|---|---|
| pre-1990 | 0 (0.00) | 23.3326 |
| 1990's | 0 (0.00) | 12.5806 |
| 2000's | 0 (0.00) | 18.1394 |
| 2010's | 2 (66.67) | 28.8240 |
| 2020's | 1 (33.33) | 9.53 |
| Drug | Indicated | Relationship Strength | Studies | Trials |
|---|---|---|---|---|
| iofetamine | 0 | low | 1 | 0 |
| trolamine salicylate | 0 | low | 1 | 0 |
| fluorodeoxyglucose f18 | 0 | low | 1 | 0 |
| ro13-9904 | 0 | low | 1 | 0 |
| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|---|---|---|---|
| arylsulfatase A | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 1 | 0 | 0 | 1 |
| Ataxin-2 | 1 | 0 | 0 | 1 |
| ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
| RAR-related orphan receptor gamma | 1 | 0 | 0 | 1 |
| retinoid X nuclear receptor alpha | 1 | 0 | 0 | 1 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | ||||